Advances in long-acting therapeutics meeting
Join us to discuss the latest breakthroughs and challenges in long-acting therapeutics at our free in-person event!
About the event
Taking place Monday 7 - Tuesday 8 October 2024, at the Liverpool Medical Institution and Conference Centre, the free Advances in Long-acting Therapeutics Meeting aims to bring together researchers in the area of long-acting therapies, from multiple disciplines, to discuss the current state-of-the-art and future opportunities. The development of long-acting therapeutics is accelerated with a multi-disciplinary approach, to ensure that the therapies being developed with desirable physical properties as materials are viable therapeutically, as well as feasible for translation into a medicinal product. We welcome input from material scientists, pharmacologists, pharmacists and industrial researchers to share current research strategies as well as help to identify challenges along the development pipeline.
The meeting will cover three main topics of discussion:
- Current long-acting therapy technologies
- Challenges within long-acting therapeutics to be addressed
- Future opportunities for development and collaboration.
Don't miss this opportunity to network with experts in the field and learn about cutting-edge research.
The agenda
We're pleased to announce our Keynote Speakers and their titles:
Professor Ryan Donnelly from the School of Pharmacy at Queen's University Belfast
- Microneedle systems for administration of long-acting therapeutics
Professor René Holm from the Department of Physics, Chemistry and Pharmacy at Syddansk Universitet (University of Southern Denmark)
- Formulating stable suspensions for long-acting applications
Monday 7 October
| 10:00 | Registration | |
Session 1 |
Chair: Professor Steve Rannard |
|
|
11:00 |
Welcome |
|
|
11:15 |
Professor René Holm University of Southern Denmark |
Formulating stable suspensions for long-acting applications |
|
12:00 |
Kevin Treacher AstraZeneca |
Nanomedicines as potential long-acting therapeutics |
|
12.30 |
Tom Starkey |
Sponsor presentation |
|
12:35 |
Lunch and poster session (sponsored by Selleck) |
|
Session 2 |
Chair: Karen Alvey |
|
|
13:35 |
Professor Steve Rannard University of Liverpool |
Long-acting therapeutics in the UK. Future considerations and opportunities |
|
14:00 |
Dr Garry Laverty Queens University Belfast |
|
|
14:30 |
Dr Tom McDonald University of Manchester |
In situ forming implants based on nanogels for long-acting drug delivery |
| 15:00 | Refreshment break | |
Session 3 – Sponsored by Marama Labs |
Chair: Laxman Cherkupally |
|
|
15:30 |
Catherine Unsworth University of Liverpool |
Preclinical development of long-acting injectable formulations of glecaprevir and pibrentasvir for hepatitis C treatment in low- and middle-income countries |
|
15:50 |
Dr Eduardo Gallardo-Toledo University of Liverpool |
|
|
16:10 |
Dr Christos Tapeinos University of Manchester |
Cell membrane-derived nanoparticles as highly selective brain-targeted drug delivery systems |
|
16:30 |
Luke Wingrave University of Liverpool |
|
|
17:00 |
Darren Andrews Marama Labs |
Sponsor presentation |
| 17:05 | Wine reception and poster session (sponsored by Selleck) | |
| 19:00 | Close | |
Tuesday 8 October
| 08:15 | Refreshments | |
Session 1 |
Chair: Andrew Owen |
|
|
09:15 |
Professor Ryan Donnelly Queens University Belfast |
Microneedle systems for administration of long-acting therapeutics |
|
10:00 |
Dr Maria Marlow University of Nottingham |
Addressing unresolved challenges in cancer therapy using localised drug delivery |
|
10:30 |
Refreshment break |
|
Session 2: Sponsored by Marks & Clerk |
Chair: Garry Laverty |
|
|
11:00 |
Dr James Hobson University of Liverpool |
Development of long-acting injectable formulations of next generation diarylquinolines for preventive therapy of tuberculosis infection |
|
11.20 |
Dr Karen Alvey University of Nottingham |
Delivering a step-change in the characterisation of complex medicines |
|
11:40 |
Ross Kelly AstraZeneca |
SubQ-Sim: A Physiologically Based Biopharmaceutics Model (PBBM) for Advancing Subcutaneous Drug Delivery |
|
12:10 |
Sam Morris University of Liverpool |
|
|
12:30 |
Representative Marks & Clerk |
Sponsor presentation |
| 12:35 | Lunch and poster session (sponsored by Selleck) | |
Session 3 |
Chair: Christos Tapeinos |
|
|
13:30 |
Laxman Cherkupally Medicines for Malaria Venture |
Long Acting Injectables - The Future of Affordable Malaria Prevention |
|
14:00 |
Mark Ryan and Prajith Venkatasubramanian University of Liverpool |
|
| 14:30 | Poster prize (sponsored by Selleck) and close | |
You can read all of the abstracts for both the oral and poster presentations here.
How do I register to attend?
To register for attendance, please click here to book a ticket on our Eventbrite page.
How do I submit an abstract for speaker or poster presentation consideration?
Abstract submissions for the 2024 Advances in Long-acting Therapeutics Meeting have now closed.
Additional considerations for presentation applicants
Presenting delegates understand that images and recordings may be taken by the CELT Global Health team for social media and advertising purposes of this and future events, please let us know if your submission if you would prefer for you and/or your work not to be included.
In order to make the presentations available to those who cannot attend, all presentations will be recorded and made available via the CELT Global Health youtube channel, if you do not wish for your presentation to be made public, please indicate this in your submission.
Please pass conference information on to your interested colleagues
We have several different assets available for you to download and share the event details to people you think will be interested.
Poster
We have a digital poster PDF for the event with incorporated links that is also ready for printing if desired. You are welcome to download the Advances in long-acting therapeutics meeting poster.
Social media assets
The 'book now' and 'submit your abstract now' images are both available as social media assets in a JPG format. Please contact us on askcelt@liverpool.ac.uk to request them.
Can I sponsor this event?
We are currently seeking sponsorship for this event. This conference is an excellent platform for potential partners to showcase their products and services to the researchers at the forefront of this rapid expanded field and facilitate potential collaborations.
Sponsorship opportunities include:
- Bronze (£50): Your logo on advertising emails and placeholder slides at the event
- Silver (£100): All Bronze benefits plus the opportunity to have a stand at the event and engage with researchers during lunch
- Gold (£200): All Silver benefits plus the opportunity to sponsor one of our main sessions (subject to availability), with specific acknowledgment at the beginning of the session and a five-minute talk about your company
- Poster prize Sponsor (£250). SOLD OUT.
We currently have one space left for stands.
If you are interested in sponsoring this event, please contact Dr Sam Naghibi by emailing sam22@liverpool.ac.uk.
Thank you for considering this opportunity. We look forward to the possibility of partnering with you.
We gratefully acknowledge financial support from the Royal Society of Chemistry collaborations grant, which has enabled this event to be free from registrations costs for delegates. Thanks also go to Selleck for sponsoring the Poster prizes and Marama Labs for event sponsorship.
